About this Webinar
Dry Eye Syndrome – Drug Forecast and Market Analysis to 2024
Speakers
Maura Musciacco, MSc
Maura Musciacco is the Director of Neurology and Ophthalmology at GlobalData in London. Prior to this role, she was a Lead Analyst for Company Analysis at Datamonitor Healthcare, where she managed the portfolio and production of the team covering the top 40 pharmaceutical companies, in addition to being the in-house specialist for the orphan drug sector. Previously, she was an Analyst in the Strategy team at Datamonitor Healthcare, where she gained extensive experience writing in-depth reports covering various topics, including mergers and acquisitions, emerging markets, generics, and R&D trends. Maura started her career in market research, where she uncovered needs and trends in specific markets. She has an MSc in International Health Management from the Imperial College Business School, and a BSc in Molecular Biology from University College London (UCL).
Catherine Daly
Catherine Daly, PhD, is a Senior Neurology and Ophthalmology Healthcare Analyst at GlobalData in London. She has a PhD in Genetics and Molecular Biology from University College Dublin, where she investigated the regulatory role of polo-like kinases in meiosis. Prior to working at GlobalData, she carried out postdoctoral research in the Neurodevelopmental Centre at King’s College London, where she identified novel phosphorylation events that affect the regulation of essential neuronal proteins. These events have important implications for both Alzheimer’s disease progression and embryonic neuronal pathfinding. She has presented her research findings at national and international conferences, and has written numerous scientific research articles. Catherine has a BSc in biochemistry from University College Cork in Ireland, where she gained a broad scientific background in numerous biological areas with particular emphasis on bioinformatics.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


